GWLL — Goldenwell Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Goldenwell Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.247	0.249	0.214	0.046	0.053
Net Total Accounts Receivable
Net Total Receivables	—	—	—	0	—
Total Inventory
Total Current Assets	0.247	0.249	0.412	0.222	0.228
Net Property, Plant And Equipment	—	—	0.049	0.026	0
Other Long Term Assets
Total Assets	0.247	0.249	0.461	0.248	0.228
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0	0	0.159	0.027	0.001
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0	0	0.159	0.047	0.143
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.247	0.249	0.302	0.202	0.085
Total Liabilities & Shareholders' Equity	0.247	0.249	0.461	0.248	0.228
Total Common Shares Outstanding